Skip to content

Pfizer Accuses J&J of Anticompetitive Business Practices over Remicade Biosimilar

Pfizer Accuses J&J of Anticompetitive Business Practices over Remicade Biosimilar Headshot

Daniel A. Kamkar

Daniel A. Kamkar’s practice focuses on worldwide patent prosecution and portfolio management, patent infringement and validity analyses, freedom to operate analyses, USPTO proceedings, and general IP licensing. Daniel currently assists...

Pfizer Accuses J&J of Anticompetitive Business Practices over Remicade Biosimilar Headshot

Eric Furman, Ph.D.

Eric S. Furman, Ph.D. focuses on patent protection and other forms of intellectual property protection for biotechnology, pharmaceuticals, and medical devices. Eric’s practice includes strategic patent counseling and procurement, freedom...